Life-Sciences-UK.com
The British Life Sciences Web Portal

This is a free web portal for the life sciences in the UK and Ireland... » read more

Quell Therapeutics Launches with £35m Series A Financing (2019-05-20)
King's and University College London (UCL) announce the foundation of a new spin-out company called Quell Therapeutics Limited. This new cell therapy company has been founded by a £35 million commitment Series A financing by Syncona who committed £34 million wit...
Rinri Therapeutics: £1.4m Seed Round Led by BIVF & UCB (2019-05-20)
Rinri Therapeutics, a biotechnology company developing a novel cellbased therapy to restore hearing, announced today that it successfully secured £1.4 million in seed funding. The financing, which was co-led by Boehringer Ingelheim Venture Fund and UCB Ventures and...
Fine Chemicals Companies Biosynth & Carbosynth Merge (2019-05-20)
Biosynth and Carbosynth announced their merger as a major step in consolidating their positions as leading suppliers in the constantly evolving fine chemical market, where mergers and acquisitions amongst the customer base of both companies have been a regular part...
ProBioGen and Vaccitech Sign License Agreement (2019-05-15)
ProBioGen AG, a premier German service & technology provider for complex biologics and Vaccitech, Ltd., a spin-out company from the University of Oxford’s Jenner Institute, one of the most renowned vaccine research centers in the world, today jointly announced sign...
F-Star: Merck KGaA to Not Excercise License Option for FS118 (2019-05-14)
> Reconfigured collaboration represents major advancement in F-star’s pivot to a wholly-owned portfolio strategy > F-star retains lead clinical asset, first-in-class bispecific antibody, FS118 > FS118 Phase 1 trial study continues according to F-star protoc...
TreeFrog Therapeutics Gets €6.5m in Equity plus €600k Grant (2019-05-13)
Funding to scale-up company’s proprietary technology C-Stem™ for mass-production of safe and affordable cell therapies TreeFrog Therapeutics, an expert stem cell company, today announces that it has raised €7.1M ($7.8M) in a Series A funding round. The proceed...
Philogen: €62m Financing Round from Private Investors (2019-05-13)
€62M funding will be used to progress wholly-owned pipeline products through clinical development and expand manufacturing activities Dr. Guido Guidi, Dr. Roberto Ferraresi and Dr. Roberto Marsella join the board of directors Philogen S.p.A (or the “C...
DyNAbind Secures Seed Financing from HTGF, TGFS & TUDAG (2019-05-07)
DyNAbind’s Dynamic DNA-Encoded Library technology platform allows hundreds of millions of chemical structures to be simultaneously screened and optimized against a potential drug target protein. This innovation continues to be driven forward with investment from th...
Transgene & AstraZeneca: Oncolytic Immunotherapies (2019-05-02)
> 5 novel oncolytic immunotherapies will be developed based on Transgene’s new Invir.IO™ platform > Transgene to receive $10 million upon signing and is eligible to receive further development milestone payments and royalties Transgene (Euronext Paris: T...
Mission Therapeutics Appoints James Summers to Board (2019-05-01)
Mission Therapeutics (“Mission”), a drug discovery and development company focused on treating mitochondrial diseases, fibrosis and neurodegenerative disorders by selectively inhibiting deubiquitylating enzymes (DUBs), today announced the appointment of Dr. James S...

Life-Sciences-UK.com is your doorway to the British and Irish life sciences!

[LSUK] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the UK and Ireland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUK] is 100% Made in Germany!

Start here with the latest News!

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

» top